arrow
P

Paul Gesta

Centre Hospitalier de Niort
H指数:24
被引数:2,362

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)

来曲唑预防携带BRCA1/2突变的绝经后女性乳腺癌(LIBER研究)

2025-11-070
PRE
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease

在法国女性中,乳腺癌的多基因风险评分的关联和表现是否具有该疾病的家族性易感性

2023-01-013
OAAI
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach
2021-10-0121
OAAI
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
2021-08-034
OAAI
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
2021-07-0137
OAAI
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility
2021-01-094
OAAI
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
2018-11-1356
OAAI
GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers

GEMO,研究BRCA1和BRCA2致病性变异携带者中乳腺癌和卵巢癌风险的遗传修饰因素的国家资源

2018-10-3113
OAAI
Familial hematological malignancies: new IDH2 mutation

家族性血液系统恶性肿瘤: 新的IDH2突变

2016-09-036
PREAI
Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies
2016-04-233
PREAI
GENESIS: a French national resource to study the missing heritability of breast cancer
2016-01-1214
OAAI
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
2015-06-0137
OAAI
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk
2015-04-1513
OAAI
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers
2015-03-3118
OAAI
Germline BAP1 Mutations Predispose to Renal Cell Carcinomas

种系BAP1突变易患肾细胞癌

2013-06-01212
OAAI
Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67
2013-04-239
OA
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)
2012-07-0327
OAAI